Table 2.
Rule | High risk variables | High risk outcome | Key differences in derivation and validation dataset |
---|---|---|---|
Rules predicting microbiologically defined infection | |||
PICNICC [8] | Weighted variables for malignancy type, maximum temperature, clinically unwell, WCC, haemoglobin and AMC | Microbiologically defined infection | Developed from IPD meta-analysis from 22 studies with variable inclusion and exclusion criteria |
Rules predicting adverse outcome | |||
SPOG-AE [21] | Applied after 24 h. Total score ≥ 9 = high risk | Adverse outcome defined as a serious medical complication (death, ICU or other life-threatening complication) as a result of infection, MDI and radiologically confirmed pneumonia | -Excluded inpatient onset FN. |
-Fever: ≥ 38·5 °C once or ≥38·0 °C during ≥2 h | |||
Score for preceding chemotherapy more intensive than ALL maintenance =4; haemoglobin ≥ 90=5; WCC < 300 cells/mm3 = 3; platelet <50 G/L=3 | -Neutropenia: ANC ≤ 500cells/mm3 | ||
-Bacteraemia not defined* | |||
Hakim [22] | Total score ≥ 24 = high risk | Proven invasive bacterial infection defined as isolation of a pathogen from a sterile body site or as proven by histology or culture-negative sepsis defined as a systemic response to a possible infection because of hemodynamic instability, focal or multiple organ involvement or altered mental status or lethargy | -Excluded inpatient onset FN |
Score for cancer diagnosis: AML=20, ALL/lymphoma = 7, solids = 0 points; Seriously unwell⁎⁎ = 14 points; temperature ≥39 °C = 11 points; ANC <100 cells/mm3 = 10 points | Bacteraemia defined as a recognized pathogen cultured from one or more blood cultures or common commensals cultured from two or more blood cultures | -Fever: ≥38·3 °C or ≥ 38·0 °C for ≥1 h | |
Alexander [23] | Any of following = high risk | Adverse outcome defined as identification of a pathogen or where there was a serious medical complication or death | -Excluded inpatient onset FN. |
AML, Burkitt lymphoma, ALL in induction, progressive or relapsed disease; Hypotension, tachypnea/hypoxia 94%; new CXR changes; altered mental status; severe mucositis; vomiting or abdominal pain; focal infection; other clinical reason for in-patient treatment | -Fever: >38·5 °C at presentation or within 6h | ||
-Neutropenia: ANC ≤ 500cells/mm3 | |||
-Bacteraemia,* serious medical complication,* hypotension⁎⁎⁎ and focal infection# not defined | |||
Klaassen [24] | AMC < 100 cells/mm3 | Significant bacterial infection defined as blood or urine culture positive for bacteria, interstitial or lobar consolidation on CXR, or unexpected death from infection (patient not palliative) | -Excluded comorbidity on presentation inc. severe mucositis and pneumonia |
-Fever: > 38·5 °C once or > 38·0 °C or within 12h | |||
Rules predicting bacteraemia | |||
SPOG-bacteraemia [28] | Applied after 24 h | Bacteraemia defined as at least 1x positive blood culture | -Excluded inpatient onset FN. |
Score for shaking or chills = 5; Hb ≥90 = 3; platelet <50 G/L = 3; Other need for inpatient care = 3 | -Fever: ≥ 38·5 °C once or ≥ 38·0 °C for ≥2h | ||
-Neutropenia: ANC ≤ 500cells/mm3 | |||
-Definition of bacteraemia different | |||
Ammann [27] | High risk: any of temperature >39·7 °C, comorbidity requiring inpatient care, WCC≤1000 cells/mm3, not in remission | Bacteraemia defined as at least 1x positive blood culture | -As for SPOG bacteraemia CDR |
Baorto [25] | AMC<155 cells/mm3 | Bacteraemia (not defined)* | -Excluded age <1y |
-Neutropenia – ANC < 500cells/mm3 | |||
Rackoff [26] | High risk: AMC < 100 cells/m3 and temperature ≥39 °C | Bacteraemia defined as a positive blood culture | -Excluded inpatient onset FN. |
Low risk = AMC ≥ 100 cells/mm3; intermediate risk = AMC < 100 cells/mm3 and temperature <39 °C | -Fever: ≥ 38·5 °C once or ≥ 38·0 °C 3x within 24h | ||
-Neutropenia: ANC < 500cells/mm3 | |||
-Definition of bacteraemia different |
PICNICC, Predicting Infectious ComplicatioNs In Children with Cancer; WCC, white cell count; AMC, absolute monocyte count; IPD, individual participant data; SPOG, Swiss Paediatric Oncology Group; AE, adverse event; ANC, absolute neutrophil count; ALL, acute lymphoblastic leukaemia; ICU, intensive care unit; MDI, microbiologically defined infection; AML, acute myeloid leukaemia; HSCT, haematopoietic stem cell transplant; SMC, serious medical complication; ICU, intensive care unit; PCR, polymerase chain reaction.
international consensus definition used for validation.52
defined as severe sepsis or septic shock (as per Goldstein et al.), 15 altered conscious state (Glasgow Coma Score <15 or only responsive to voice or pain), documented as ‘severely unwell’ or equivalent in the patient record or either the blood pressure or respiratory rate in the mandatory emergency call range.16
Hypotension defined according to VICTOR chart.16
Focal infection includes defined as upper respiratory tract infection (URTI), lower respiratory tract infection (LRTI), anorectal infection or central venous catheter (CVC) infection.